Copyright © 2024 · Alle Rechte vorbehalten. · Genome Editing INFOTHEK
Gemeinnützige Website von GivingPress · RSS-Feed · Anmelden
Cookie | Dauer | Beschreibung |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Erstellt am 30. September 2024 von sas
Streit um Gen-Editierung CRISPR: Warum die Erfinderinnen ihre europäischen Patente zurückziehen wollen
Im Kampf um die Kontrolle der Genom-Editierung ist die Entscheidung von Jennifer Doudna und Emmanuelle Charpentier eine überraschende Wendung. Weiterlesen bei t3n.de
Kategorie: Meinungen+Meldungen, Politik Tags: europäischen Patente, Patent CRISPR
UPDATE